These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 8346712

  • 41. Internalization and action of an immunotoxin containing mistletoe lectin A-chain.
    Wiedłocha A, Sandvig K, Walzel H, Radzikowsky C, Olsnes S.
    Cancer Res; 1991 Feb 01; 51(3):916-20. PubMed ID: 1988131
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Characterization of cytotoxic proteins from mistletoe (Viscum album L.).
    Jung ML, Baudino S, Ribéreau-Gayon G, Beck JP.
    Cancer Lett; 1990 May 30; 51(2):103-8. PubMed ID: 2344587
    [Abstract] [Full Text] [Related]

  • 44. Effect of a recombinant lectin, Viscum album agglutinin on the secretion of interleukin-12 in cultured human peripheral blood mononuclear cells and on NK-cell-mediated cytotoxicity of rat splenocytes in vitro and in vivo.
    Hajto T, Hostanska K, Weber K, Zinke H, Fischer J, Mengs U, Lentzen H, Saller R.
    Nat Immun; 1998 May 30; 16(1):34-46. PubMed ID: 9789123
    [Abstract] [Full Text] [Related]

  • 45. Heat shock treatment protects human HL-60 cells from apoptosis induced by lectin II isolated from Korean mistletoe, Visum album var. Coloratum.
    Pae HO, Seo WG, Shin M, Lee HS, Lee HS, Kim SB, Chung HT.
    Immunopharmacol Immunotoxicol; 2000 May 30; 22(2):237-52. PubMed ID: 10952029
    [Abstract] [Full Text] [Related]

  • 46. Differences in the apoptosis-inducing properties of Viscum album L. extracts.
    Büssing A, Suzart K, Schweizer K.
    Anticancer Drugs; 1997 Apr 30; 8 Suppl 1():S9-14. PubMed ID: 9179360
    [Abstract] [Full Text] [Related]

  • 47. A new gene encoding the ribosome-inactivating protein from mistletoe extracts.
    Tonevitsky AG, Agapov II, Pevzner IB, Maluchenko NV, Moisenovich MM, Palmer RA, Yurkova M, Pfüller K, Pfüller U.
    Arzneimittelforschung; 2004 Apr 30; 54(4):242-9. PubMed ID: 15146937
    [Abstract] [Full Text] [Related]

  • 48. A plant lectin derived from Viscum album induces cytokine gene expression and protein production in cultures of human peripheral blood mononuclear cells.
    Hostanska K, Hajto T, Spagnoli GC, Fischer J, Lentzen H, Herrmann R.
    Nat Immun; 1995 Sep 30; 14(5-6):295-304. PubMed ID: 8933823
    [Abstract] [Full Text] [Related]

  • 49. [Mistletoe therapy from the pharmacologic perspective].
    Hajto T, Hostanska K, Saller R.
    Forsch Komplementarmed; 1999 Aug 30; 6(4):186-94. PubMed ID: 10529578
    [Abstract] [Full Text] [Related]

  • 50. Lack of an antitumoral effect of immunomodulatory galactoside-specific mistletoe lectin on N-methyl-N-nitrosourea-induced urinary bladder carcinogenesis in rats.
    Kunze E, Schulz H, Ahrens H, Gabius HJ.
    Exp Toxicol Pathol; 1997 Aug 30; 49(3-4):167-80. PubMed ID: 9314050
    [Abstract] [Full Text] [Related]

  • 51. Toxic proteins from European mistletoe (Viscum album L.): increase of intracellular IL-4 but decrease of IFN-gamma in apoptotic cells.
    Stein GM, Pfüller U, Schietzel M, Büssing A.
    Anticancer Res; 2000 Aug 30; 20(3A):1673-8. PubMed ID: 10928090
    [Abstract] [Full Text] [Related]

  • 52. Cytokine release of whole blood from adult female donors challenged with mistletoe lectin-1 standardised mistletoe extract and E. coli endotoxin or phytohaemagglutinin (PHA).
    Braun JM, Blackwell CC, Weir DM, Beuth J.
    Anticancer Res; 2003 Aug 30; 23(2B):1349-52. PubMed ID: 12820393
    [Abstract] [Full Text] [Related]

  • 53. Characterization of a toxic lectin in Iscador, a mistletoe preparation with alleged cancerostatic properties.
    Holtskog R, Sandvig K, Olsnes S.
    Oncology; 1988 Aug 30; 45(3):172-9. PubMed ID: 3368193
    [Abstract] [Full Text] [Related]

  • 54. Mistletoe lectin activates caspase-8/FLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosis.
    Bantel H, Engels IH, Voelter W, Schulze-Osthoff K, Wesselborg S.
    Cancer Res; 1999 May 01; 59(9):2083-90. PubMed ID: 10232592
    [Abstract] [Full Text] [Related]

  • 55. Modulation of mistletoe (Viscum album L.) lectins cytotoxicity by carbohydrates and serum glycoproteins.
    Frantz M, Jung ML, Ribereau-Gayon G, Anton R.
    Arzneimittelforschung; 2000 May 01; 50(5):471-8. PubMed ID: 10858875
    [Abstract] [Full Text] [Related]

  • 56. Induction of antibodies to viscotoxins A1, A2, A3, and B in tumour patients during therapy with an aqueous mistletoe extract.
    Klein R, Classen K, Fischer S, Errenst M, Scheffler A, Stein GM, Scheer R, von Laue HB.
    Eur J Med Res; 2002 Aug 30; 7(8):359-67. PubMed ID: 12204844
    [Abstract] [Full Text] [Related]

  • 57. Treatment of advanced pancreatic cancer with mistletoe: results of a pilot trial.
    Friess H, Beger HG, Kunz J, Funk N, Schilling M, Büchler MW.
    Anticancer Res; 1996 Aug 30; 16(2):915-20. PubMed ID: 8687151
    [Abstract] [Full Text] [Related]

  • 58. Generation of reactive oxygen intermediates (ROI) by the thionins from Viscum album L.
    Büssing A, Schaller G, Pfüller U.
    Anticancer Res; 1998 Aug 30; 18(6A):4291-6. PubMed ID: 9891480
    [Abstract] [Full Text] [Related]

  • 59. Cytotoxic activity and absence of tumor growth stimulation of standardized mistletoe extracts in human tumor models in vitro.
    Kelter G, Schierholz JM, Fischer IU, Fiebig HH.
    Anticancer Res; 2007 Aug 30; 27(1A):223-33. PubMed ID: 17352237
    [Abstract] [Full Text] [Related]

  • 60. Binding of mistletoe lectins to cutaneous malignant melanoma: implications for prognosis and therapy.
    Thies A, Pfüller U, Schachner M, Horny HP, Molls I, Schumacher U.
    Anticancer Res; 2001 Aug 30; 21(4B):2883-7. PubMed ID: 11712781
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.